Fabio Arcidiacono
Overview
Explore the profile of Fabio Arcidiacono including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Francolini G, Bertini N, Di Cataldo V, Garlatti P, Aquilano M, Caini S, et al.
Prostate Cancer Prostatic Dis
. 2025 Feb;
PMID: 39972049
ARTO trial was a phase II randomized trial suggesting the benefit of a concomitant treatment strategy including Abiraterone acetate plus predisone (AAP) and stereotactic body radiotherapy (SBRT) in oligometastatic castrate...
2.
Viani G, Gouveia A, Arcidiacono F, Marta G, Hamamura A, Anselmo P, et al.
Rep Pract Oncol Radiother
. 2024 Aug;
29(3):309-317.
PMID: 39144263
Background: Diffuse intrinsic pontine glioma (DIPG) stands as the predominant type of brainstem glioma. It is characterized by a notably brief median survival period, with the majority of patients experiencing...
3.
Viani G, Gouveia A, Louie A, Arcidiacono F, Simone 2nd C, Tsakiridis T, et al.
Radiother Oncol
. 2024 Jul;
201:110439.
PMID: 39032835
Introduction: To evaluate the feasibility, efficacy and safety of stereotactic ablative radiotherapy (SABR) to the primary tumor and lymph nodes in patients with locally advanced non-small cell lung cancer (LA-NSCLC)...
4.
Pezzulla D, Di Franco R, Zamagni A, Pastore F, Longo S, Dominici L, et al.
Br J Radiol
. 2023 Sep;
96(1151):20230124.
PMID: 37751164
Objectives: We search the current literature on data regarding the role of RT in OM treatment, focusing on the improvement of symptoms and patient quality of life. Methods: This systematic...
5.
Arcidiacono F, Anselmo P, Casale M, Trippa F
Radiother Oncol
. 2023 May;
185:109688.
PMID: 37164107
No abstract available.
6.
Cellini F, Di Rito A, Siepe G, Pastore F, Lattanzi E, Meaglia I, et al.
Adv Radiat Oncol
. 2023 Jan;
8(2):101134.
PMID: 36632087
Purpose: Bone metastases frequently occur during malignant disease. Palliative radiation therapy (PRT) is a crucial part of palliative care because it can relieve pain and improve patients' quality of life....
7.
Casale M, Draghini L, Trippa F, Costantini S, Vicenzi L, Tesei L, et al.
J Contemp Brachytherapy
. 2022 Dec;
14(5):470-475.
PMID: 36478699
Purpose: To evaluate the reliability of algebraic sum with respect to rigid fusion of treatment plans related to adjuvant external beam pelvic radiotherapy (APR) and vaginal cuff high-dose-rate brachytherapy (BT)...
8.
Arcidiacono F, Anselmo P, Casale M, Zannori C, Ragusa M, Mancioli F, et al.
Int J Radiat Oncol Biol Phys
. 2022 Oct;
115(4):886-896.
PMID: 36288758
Purpose: This is a single arm phase 2 trial (Clinical trials.gov NCT05291780) to assess local control (LC) and safety of SAbR in patients with unresectable locally advanced non-small cell lung...
9.
Pergolizzi S, Cacciola A, Parisi S, Lillo S, Tamburella C, Santacaterina A, et al.
Rep Pract Oncol Radiother
. 2022 Oct;
27(3):419-427.
PMID: 36186686
Background: The aim of this paper is to provide a comprehensive overview of the scenario on radiotherapy (RT) delivered with palliative intent in Italy. Materials And Methods: A structured online...
10.
Di Franco R, Pezzulla D, Arcidiacono F, Pontoriero A, Cellini F, Belgioia L, et al.
Clin Transl Oncol
. 2022 Sep;
25(2):408-416.
PMID: 36163444
Aim: This survey derived from the collaboration between the Palliative Care and Reirradiation Study Groups of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Its aim was to obtain...